Peggy W G du Buf-Vereijken

Cytotoxic therapy for membranous nephropathy and renal insufficiency: improved renal survival but high relapse rate

Peggy W G du Buf-Vereijken, A. J. W. Branten, Jack F.M. Wetzels · Nephrology Dialysis Transplantation · 2004 · 94 citations · Full text

Possible increased risk of rhabdomyolysis during concomitant use of simvastatin and gemfibrozil

Eugène van Puijenbroek, Peggy W G du Buf-Vereijken, P. F. M. J. Spooren et al. · Journal of Internal Medicine · 1996 · 66 citations

Early versus late start of immunosuppressive therapy in idiopathic membranous nephropathy: a randomized controlled trial

Julia M. Hofstra, A. J. W. Branten, J.J.J.M. Wirtz et al. · Nephrology Dialysis Transplantation · 2009 · 62 citations

Restrictive use of immunosuppressive treatment in patients with idiopathic membranous nephropathy: high renal survival in a large patient cohort

Peggy W G du Buf-Vereijken, Geert W. Feith, Daan A M J Hollander et al. · QJM · 2004 · 26 citations · Full text

Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity

Peggy W G du Buf-Vereijken, Jack F.M. Wetzels · Nephrology Dialysis Transplantation · 2004 · 19 citations